E
ENGN//CIK 0001980845
enGene Therapeutics Inc.
Market Data
$1.90+$0.30 (+18.75%)
ENGN · Last trade
Prev Close
$1.60
Range (29d)
$1.62 – $1.92
Recent Filings
- 8-K/A203.0 KBenGene Therapeutics Inc.Jun 18, 4:06 PM ET·0001193125-26-275815
- 10-Q11.8 MBenGene Therapeutics Inc.Jun 15, 9:16 AM ET·0001193125-26-270386
- 8-K451.7 KBenGene Therapeutics Inc.Jun 15, 9:14 AM ET·0001193125-26-270384
- 8-K217.1 KBenGene Therapeutics Inc.Jun 10, 4:09 PM ET·0001193125-26-265830
- 8-K2.4 MBenGene Therapeutics Inc.May 7, 7:11 AM ET·0001193125-26-210316
- 8-K1.3 MBenGene Therapeutics Inc.Apr 9, 4:02 PM ET·0001193125-26-149597
- 8-K735.4 KBenGene Holdings Inc.Mar 9, 7:15 AM ET·0001193125-26-097546
- 10-Q10.3 MBenGene Holdings Inc.Mar 9, 7:09 AM ET·0001193125-26-097541
- 8-K356.3 KBenGene Holdings Inc.Mar 9, 7:04 AM ET·0001193125-26-097534
- 10-K/A1.3 MBenGene Holdings Inc.Feb 19, 4:15 PM ET·0001193125-26-059409
Insiders
10- Astley-Sparke PhilipDirector
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- BRUNK GERALD ADirector
- BRYCE RICHARD PAULChief Medical Officer
- BVF GP HOLDINGS LLC10% Owner
- BVF I GP LLCSee Explanation of Responses
- BVF II GP LLCSee Explanation of Responses
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- BVF Partners OS Ltd.See Explanation of Responses
Tickers
Addresses
business
4868 RUE LEVY, SUITE 220
SAINT-LAURENT
mailing
4868 RUE LEVY, SUITE 220
SAINT-LAURENT
Former Names
- enGene Holdings Inc.2026-03-09